Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes throughout the brain. Magnetic resonance imaging can be used to investigate the regional distribu-tion of cortical atrophy in AD in vivo. One marker for the disease-specific atrophy is the thickness of the cortical mantle across the brain, obtained with automated 3-D image processing. Here, we present data from 36 subjects (17 controls and, 19 patients diagnosed as probable AD) investigated for cortical thickness across the entire brain. We show significant cortical thickness decline in AD in temporal, orbitofrontal and parietal regions, with the most pro-nounced changes occurring in the allocortical region of the medial temporal lobes, outlini...
This dissertation describes a series of investigations designed to establish in-vivo analysis of cor...
Population-based brain mapping provides great insight into the trajectory of aging and dementia, as ...
This study examines the atrophy rates of subjects with mild cognitive impairment (MCI) compared to c...
Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes th...
Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes th...
Regions of the temporal and parietal lobes are particularly damaged in Alzheimer's disease (AD), and...
Alzheimer's disease (AD) is associated with neurodegeneration in vulnerable limbic and heteromodal r...
Progressive brain atrophy is believed to be the Alzheimer’s disease (AD) marker with the greatest ev...
Magnetic resonance imaging--based volumetric measurements pro-vide a useful technique for quantifyin...
Prior studies have shown that patients with AD have decreased functional or structural connectivity ...
Magnetic resonance imaging--based volumetric measurements pro-vide a useful technique for quantifyin...
MRI studies have consistently identified atrophy patterns in Alzheimer’s disease (AD) through a whol...
AbstractIntroductionRecent studies have shown that pathologically defined subtypes of Alzheimer's di...
Magnetic resonance imaging-based volumetric measurements provide a useful technique for quantifying ...
Objective: Because the signs associated with dementia due to Alzheimer disease (AD) can be heterogen...
This dissertation describes a series of investigations designed to establish in-vivo analysis of cor...
Population-based brain mapping provides great insight into the trajectory of aging and dementia, as ...
This study examines the atrophy rates of subjects with mild cognitive impairment (MCI) compared to c...
Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes th...
Alzheimer’s disease (AD) is characterized by a heterogeneous distribution of pathological changes th...
Regions of the temporal and parietal lobes are particularly damaged in Alzheimer's disease (AD), and...
Alzheimer's disease (AD) is associated with neurodegeneration in vulnerable limbic and heteromodal r...
Progressive brain atrophy is believed to be the Alzheimer’s disease (AD) marker with the greatest ev...
Magnetic resonance imaging--based volumetric measurements pro-vide a useful technique for quantifyin...
Prior studies have shown that patients with AD have decreased functional or structural connectivity ...
Magnetic resonance imaging--based volumetric measurements pro-vide a useful technique for quantifyin...
MRI studies have consistently identified atrophy patterns in Alzheimer’s disease (AD) through a whol...
AbstractIntroductionRecent studies have shown that pathologically defined subtypes of Alzheimer's di...
Magnetic resonance imaging-based volumetric measurements provide a useful technique for quantifying ...
Objective: Because the signs associated with dementia due to Alzheimer disease (AD) can be heterogen...
This dissertation describes a series of investigations designed to establish in-vivo analysis of cor...
Population-based brain mapping provides great insight into the trajectory of aging and dementia, as ...
This study examines the atrophy rates of subjects with mild cognitive impairment (MCI) compared to c...